Saint-Louis Hospital, Paris, France
40
3
8
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.0%
2 terminated/withdrawn out of 40 trials
90.9%
+4.4% vs industry average
3%
1 trials in Phase 3/4
5%
1 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (40)
Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group
Role: lead
Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia
Role: collaborator
SENOVIE France - Therapeutic Mobility and Breast Cancer
Role: collaborator
Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV
Role: collaborator
Evaluating the Effectiveness of the "Hello Bundle" Intervention in Reducing Burnout Among ICU Healthcare Professionals
Role: lead
Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning
Role: collaborator
Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia
Role: collaborator
French National Observatory on Infective Endocarditis
Role: collaborator
RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms
Role: collaborator
Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)
Role: collaborator
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
Role: collaborator
Cohort IMEA 070 -Lenacapavir Compassional
Role: collaborator
Validation Study of the Feasibility of an Integrated Diagnostic System of Anatomo-pathological Lesions - Including Rejections - Appearing in Renal Grafts in the First Year of Transplant for Applicability in Routine Clinical Practice : KTD Innov-2 Study
Role: collaborator
Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss
Role: collaborator
Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination
Role: collaborator
Socio-psychological Factors Involved in the Hematopoietic Stem Cell Transplantation Process in People With Hemopathies
Role: lead
Shock and Acute Conditions OutcOmes Platform
Role: lead
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Role: collaborator
MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies
Role: collaborator
A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)
Role: collaborator